SMAD4 and colorectal carcinoma: Using human clinical specimens, we have also showed that loss of SMAD4 promotes CCL15 expression from CRC cells to recruit CCR1+ myeloid cells, which facilitates primary tumor invasion and liver metastasis of CRC [40,42].